Fate Therapeutics, Inc.FATENASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-123.60M
↓ 21% below average
Average (9y)
$-102.39M
Historical baseline
Range
High:$-19.89M
Low:$-283.77M
CAGR
+22.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-123.60M | +10.7% |
| 2023 | $-138.42M | +51.2% |
| 2022 | $-283.77M | -32.9% |
| 2021 | $-213.57M | -383.6% |
| 2020 | $-44.16M | +51.2% |
| 2019 | $-90.57M | -121.2% |
| 2018 | $-40.95M | -6.0% |
| 2017 | $-38.63M | -27.6% |
| 2016 | $-30.28M | -52.2% |
| 2015 | $-19.89M | - |